Cost-effectiveness of apixaban and rivaroxaban in thromboprophylaxis of cancer patients treated with chemotherapy in Spain.
J Med Econ
; 26(1): 1145-1154, 2023.
Article
in En
| MEDLINE
| ID: mdl-37602646
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Venous Thromboembolism
/
Neoplasms
Type of study:
Clinical_trials
/
Health_economic_evaluation
/
Prognostic_studies
Limits:
Adult
/
Humans
Country/Region as subject:
Europa
Language:
En
Journal:
J Med Econ
Journal subject:
SERVICOS DE SAUDE
Year:
2023
Type:
Article
Affiliation country:
Spain